BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36948086)

  • 1. Metabolomic profiling reveals bacterial metabolic adaptation strategies and new metabolites.
    Wang H; de Carvalho LPS
    Curr Opin Chem Biol; 2023 Jun; 74():102287. PubMed ID: 36948086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass spectrometry-based metabolomics: applications to biomarker and metabolic pathway research.
    Zhang A; Sun H; Yan G; Wang P; Wang X
    Biomed Chromatogr; 2016 Jan; 30(1):7-12. PubMed ID: 25739660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomic strategies for the identification of new enzyme functions and metabolic pathways.
    Prosser GA; Larrouy-Maumus G; de Carvalho LP
    EMBO Rep; 2014 Jun; 15(6):657-69. PubMed ID: 24829223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomics in infectious diseases and drug discovery.
    Tounta V; Liu Y; Cheyne A; Larrouy-Maumus G
    Mol Omics; 2021 Jun; 17(3):376-393. PubMed ID: 34125125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomic changes in vertebrate host during malaria disease progression.
    Ghosh S; Pathak S; Sonawat HM; Sharma S; Sengupta A
    Cytokine; 2018 Dec; 112():32-43. PubMed ID: 30057363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolomics for Clinical Biomarker Discovery and Therapeutic Target Identification.
    Lin C; Tian Q; Guo S; Xie D; Cai Y; Wang Z; Chu H; Qiu S; Tang S; Zhang A
    Molecules; 2024 May; 29(10):. PubMed ID: 38792060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass spectrometry-based metabolomics: Targeting the crosstalk between gut microbiota and brain in neurodegenerative disorders.
    Luan H; Wang X; Cai Z
    Mass Spectrom Rev; 2019 Jan; 38(1):22-33. PubMed ID: 29130504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging Applications of Metabolomics in Clinical Pharmacology.
    Pang H; Jia W; Hu Z
    Clin Pharmacol Ther; 2019 Sep; 106(3):544-556. PubMed ID: 31173340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomics approaches for characterizing metabolic interactions between host and its commensal microbes.
    Xie G; Zhang S; Zheng X; Jia W
    Electrophoresis; 2013 Oct; 34(19):2787-98. PubMed ID: 23775228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomics approach based on utra-performance liquid chromatography coupled to mass spectrometry with chemometrics methods for high-throughput analysis of metabolite biomarkers to explore the abnormal metabolic pathways associated with myocardial dysfunction.
    Zhao LK; Zhao YB; Yu PC; Zhang PX
    Biomed Chromatogr; 2020 Aug; 34(8):e4847. PubMed ID: 32285481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAIRUP-MS: Pathway analysis and imputation to relate unknowns in profiles from mass spectrometry-based metabolite data.
    Hsu YH; Churchhouse C; Pers TH; Mercader JM; Metspalu A; Fischer K; Fortney K; Morgen EK; Gonzalez C; Gonzalez ME; Esko T; Hirschhorn JN
    PLoS Comput Biol; 2019 Jan; 15(1):e1006734. PubMed ID: 30640898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass Spectrometry-Based Microbial Metabolomics: Techniques, Analysis, and Applications.
    Baidoo EEK; Teixeira Benites V
    Methods Mol Biol; 2019; 1859():11-69. PubMed ID: 30421222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum global metabolomics profiling reveals profound metabolic impairments in patients with MPS IIIA and MPS IIIB.
    Fu H; Meadows AS; Pineda RJ; Mohney RP; Stirdivant S; McCarty DM
    Metab Brain Dis; 2017 Oct; 32(5):1403-1415. PubMed ID: 28382573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel strategies for clinical investigation and biomarker discovery: a guide to applied metabolomics.
    Carneiro G; Radcenco AL; Evaristo J; Monnerat G
    Horm Mol Biol Clin Investig; 2019 Jan; 38(3):. PubMed ID: 30653466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbial Metabolomics: A General Overview.
    Baidoo EEK
    Methods Mol Biol; 2019; 1859():1-8. PubMed ID: 30421221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultraperformance liquid chromatography-mass spectrometry based comprehensive metabolomics combined with pattern recognition and network analysis methods for characterization of metabolites and metabolic pathways from biological data sets.
    Zhang AH; Sun H; Han Y; Yan GL; Yuan Y; Song GC; Yuan XX; Xie N; Wang XJ
    Anal Chem; 2013 Aug; 85(15):7606-12. PubMed ID: 23845028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolomics in systems microbiology.
    Reaves ML; Rabinowitz JD
    Curr Opin Biotechnol; 2011 Feb; 22(1):17-25. PubMed ID: 21050741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomics in rheumatic diseases: desperately seeking biomarkers.
    Guma M; Tiziani S; Firestein GS
    Nat Rev Rheumatol; 2016 May; 12(5):269-81. PubMed ID: 26935283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-platform 'multi-omic' profiling: unified mass spectrometry and computational workflows for integrative proteomics-metabolomics analysis.
    Blum BC; Mousavi F; Emili A
    Mol Omics; 2018 Oct; 14(5):307-319. PubMed ID: 30211418
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.